Based on data generated using these types of engineered antigens for malaria-based serological surveys, as well as our previous report on the high frequency of antibodies to PvRMC-MSP1 in individuals living in a malaria endemic area, it was sought to assess the ability of PvRMC-MSP1 to act as a pan-Plasmodium antigen target for serological surveys. This evidence concerns the gene ATAD1 and malaria.